This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
Recursion Pharmaceuticals (RXRX) Soars 5.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Recursion Pharmaceuticals (RXRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
RXRXNegative Net Change ANIKNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Chemung Financial (CHMG)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
CHMGNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Invesco (IVZ) Surges 15.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
Invesco (IVZ) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
IVZNegative Net Change SAMGNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Radcom (RDCM): Can Its 11.4% Jump Turn into More Strength?
by Zacks Equity Research
Radcom (RDCM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
RDCMNegative Net Change NTCTNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Eos Energy Enterprises (EOSE) Surges 10.8%: Is This an Indication of Further Gains?
by Zacks Equity Research
Eos Energy Enterprises (EOSE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
EOSEPositive Net Change LZNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Materion (MTRN): Can Its 6.3% Jump Turn into More Strength?
by Zacks Equity Research
Materion (MTRN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
MTRNNo Net Change GSMNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in California Resources (CRC): Can Its 6.7% Jump Turn into More Strength?
by Zacks Equity Research
California Resources (CRC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CRCNegative Net Change MNRPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Cheniere Energy (LNG) Soars 5.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Cheniere Energy (LNG) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
LNGNegative Net Change NOGNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Zeta (ZETA) Moves 6.2% Higher: Will This Strength Last?
by Zacks Equity Research
Zeta (ZETA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
ZETANegative Net Change TTECPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
BlackSky Technology (BKSY) Moves 8.9% Higher: Will This Strength Last?
by Zacks Equity Research
BlackSky Technology (BKSY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
BKSYNegative Net Change ALLTNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Pagaya Technologies Ltd. (PGY) Soars 25.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Pagaya Technologies Ltd. (PGY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
PGYNegative Net Change XPPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in StepStone Group (STEP): Can Its 6.0% Jump Turn into More Strength?
by Zacks Equity Research
StepStone Group (STEP) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
STEPNegative Net Change HLINegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
BeOne Medicines Ltd. - Sponsored ADR (ONC) Surges 4.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
BeOne Medicines Ltd. - Sponsored ADR (ONC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
ONCNegative Net Change MGXNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Zymeworks (ZYME) Surges 7.1%: Is This an Indication of Further Gains?
by Zacks Equity Research
Zymeworks (ZYME) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
ZYMENegative Net Change CYTKPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Should You Buy Datadog (DDOG) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
DDOGNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Western Digital (WDC) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
WDCPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Enovix Corporation (ENVX) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
ENVXNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Evercore (EVR) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
EVRNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Strength Seen in Ambac (AMBC): Can Its 17.7% Jump Turn into More Strength?
by Zacks Equity Research
Ambac (AMBC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
AMBCNegative Net Change RLINegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Townsquare (TSQ) Surges 6.9%: Is This an Indication of Further Gains?
by Zacks Equity Research
Townsquare (TSQ) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
TSQNegative Net Change IHRTNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Legend Biotech (LEGN) Surges 6.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
Legend Biotech (LEGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
LEGNNegative Net Change VNDANegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Belden (BDC): Can Its 3.6% Jump Turn into More Strength?
by Zacks Equity Research
Belden (BDC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
BDCPositive Net Change ATKRNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
SYMBOTIC INC (SYM) Moves 8.7% Higher: Will This Strength Last?
by Zacks Equity Research
SYMBOTIC INC (SYM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
SYMNegative Net Change BLDENegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Rigetti Computing (RGTI) Surges 30.2%: Is This an Indication of Further Gains?
by Zacks Equity Research
Rigetti Computing (RGTI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
RGTINegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Brighthouse Financial (BHF): Can Its 6.2% Jump Turn into More Strength?
by Zacks Equity Research
Brighthouse Financial (BHF) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
BHFNegative Net Change PRINegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today